Telangiectasia Clinical Trials in Bron
2 recruitingBron, France
Showing 1–2 of 2 trials
Recruiting
Phase 1Phase 2
A Study to Evaluate ALN-6400 in Healthy Volunteers and Patients With Hereditary Hemorrhagic Telangiectasia (HHT)
Hereditary hemorrhagic telangiectasia
Alnylam Pharmaceuticals120 enrolled16 locationsNCT06659640
Recruiting
Phase 2
Efficacy of Nintedanib for Treatment of Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT) Patients
Telangiectasia, Hereditary Hemorrhagic
Dr. Romain Lazor48 enrolled3 locationsNCT04976036